Profitability
Weight: 25%
D-
30
- 5yr Avg ROIC -7.0%
- Operating Margin Trend +94.79 pp/yr
AUPH
Aurinia Pharmaceuticals Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
16
- 5yr Avg ROE -2.6%
- 5yr Share-Count CAGR 1.8%
Growth Quality
Weight: 25%
A+
96
- 5yr Revenue CAGR 57.8%
- 5yr EPS CAGR 5167.2%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
D-
29
- 5yr FCF Margin -72.3%
- 5yr FCF/NI Conversion 4.07x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -2.53x
- Interest Coverage (EBIT/Int) 27.36x
- Altman Z-Score 8.06
Stability
Weight: 5%
A-
85
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 6
- Negative-Revenue Years (5) 1/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 2 added.
- Holders
- 2
- Avg Δ position
- +17.5%
- New buys
- 0
- Full exits
- 0
- Greenblatt increased +32%
- Cooperman increased +3%